Pacer Advisors Inc. Purchases 339,301 Shares of Concentrix Corporation $CNXC

Pacer Advisors Inc. raised its position in Concentrix Corporation (NASDAQ:CNXC) by 2,107.6% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 355,400 shares of the company’s stock after buying an additional 339,301 shares during the period. Pacer Advisors Inc.’s holdings in Concentrix were worth $9,724,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. Larson Financial Group LLC increased its holdings in shares of Concentrix by 224.9% during the third quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock worth $32,000 after buying an additional 479 shares in the last quarter. Geneos Wealth Management Inc. boosted its holdings in shares of Concentrix by 532.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after acquiring an additional 522 shares in the last quarter. Global Retirement Partners LLC boosted its holdings in shares of Concentrix by 1,032.5% in the 4th quarter. Global Retirement Partners LLC now owns 872 shares of the company’s stock worth $36,000 after acquiring an additional 795 shares in the last quarter. Webster Bank N. A. bought a new stake in Concentrix during the 1st quarter worth approximately $41,000. Finally, Rothschild Investment LLC grew its position in Concentrix by 52.0% during the 4th quarter. Rothschild Investment LLC now owns 1,146 shares of the company’s stock worth $48,000 after acquiring an additional 392 shares during the last quarter. 90.34% of the stock is owned by institutional investors.

Concentrix Stock Up 2.2%

NASDAQ CNXC opened at $25.50 on Wednesday. The stock has a market capitalization of $1.56 billion, a P/E ratio of -1.20, a price-to-earnings-growth ratio of 0.46 and a beta of 0.45. Concentrix Corporation has a 52 week low of $19.12 and a 52 week high of $57.88. The company has a debt-to-equity ratio of 1.46, a quick ratio of 1.18 and a current ratio of 1.18. The stock has a fifty day moving average of $25.02 and a 200-day moving average of $28.90.

Concentrix (NASDAQ:CNXC) last issued its quarterly earnings results on Monday, June 29th. The company reported $2.63 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.64 by ($0.01). The firm had revenue of $2.46 billion for the quarter, compared to analyst estimates of $2.47 billion. Concentrix had a negative net margin of 13.16% and a positive return on equity of 19.82%. The company’s revenue was up 1.9% compared to the same quarter last year. During the same period last year, the company earned $2.70 EPS. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. On average, equities research analysts forecast that Concentrix Corporation will post 9.67 EPS for the current year.

Concentrix Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, August 4th. Shareholders of record on Friday, July 24th were given a dividend of $0.36 per share. The ex-dividend date was Friday, July 24th. This represents a $1.44 dividend on an annualized basis and a yield of 5.6%. Concentrix’s dividend payout ratio is presently -6.75%.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the company. Canaccord Genuity Group cut their price objective on Concentrix from $55.00 to $45.00 and set a “buy” rating for the company in a research report on Tuesday, June 30th. Robert W. Baird decreased their target price on Concentrix from $40.00 to $30.00 and set an “outperform” rating on the stock in a report on Tuesday, June 30th. Weiss Ratings restated a “sell (d)” rating on shares of Concentrix in a research note on Friday, July 24th. Zacks Research cut Concentrix from a “hold” rating to a “strong sell” rating in a report on Thursday, July 2nd. Finally, Barrington Research cut their price target on Concentrix from $38.00 to $30.00 and set an “outperform” rating for the company in a report on Tuesday, June 30th. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $32.75.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology?driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back?office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.